LiverCell

LiverCell is a biotechnology company focused on liver regeneration through a combination of bioelectric stimulation and biologics. As part of the Leonhardt Ventures portfolio, the company utilizes a proprietary platform to deliver precise bioelectric signals that trigger the controlled expression of regenerative proteins and the homing of stem cells to the liver. Their primary goal is to treat liver failure and prevent tumor progression by restoring healthy organ function. The company's approach integrates implantable or wearable stimulators with regenerative compositions to provide a multi-modal therapeutic solution. Currently in the early clinical pilot stage, LiverCell aims to offer a non-invasive alternative to traditional liver transplantation.